2016
The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions.
Hamoudeh E, Zeidan AM, Barbarotta L, Rosano N. The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions. Current Diabetes Reviews 2016, 12: 231-9. PMID: 26008639, DOI: 10.2174/1573399811666150526151241.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsDiabetes ComplicationsDiabetes MellitusDisease ProgressionEvidence-Based MedicineHumansHyperglycemiaMyelodysplastic SyndromesNeoplasmsConceptsDiabetes mellitusMyelodysplastic syndromeDiabetic patientsManagement of MDSOutcomes of patientsEnd-organ damageRisk of progressionRisk of complicationsCommon hematologic malignancyIntensive therapeutic interventionMultiple epidemiologic studiesAcute myeloid leukemiaLow blood countsDiabetic controlAdjunct drugsGlucose controlBlood countImportant unmetInsulin resistanceDysplastic changesHematologic malignanciesRisk factorsMyeloid leukemiaEpidemiologic studiesTherapeutic interventions
2014
Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies
Liao C, Zhang D, Mungo C, Tompkins DA, Zeidan AM. Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. Gynecologic Oncology 2014, 135: 163-171. PMID: 25072931, PMCID: PMC4404750, DOI: 10.1016/j.ygyno.2014.07.095.Peer-Reviewed Original ResearchMeSH KeywordsCause of DeathCohort StudiesDiabetes ComplicationsEndometrial NeoplasmsFemaleHumansIncidenceConceptsDisease-specific mortalityIncident endometrial cancerEndometrial cancerDiabetes mellitusCohort studyRelative riskStatistical heterogeneityIncidence of ECSummary incidence rate ratioEC-specific mortalityOriginal cohort studyNon-diabetic womenSummary relative riskCochrane's Q statisticIncidence rate ratiosRisk of biasStandardized mortality ratioSignificant statistical heterogeneitySmall-study effectsChi-square testDM statusGynecological oncologyIndependent associationMortality ratioEgger's test